Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%). We observed no increase in the seroprevalence trend after widespread school reopening....
Main Authors: | Rebecca A. Falender, Paul G. Mitchell, Judith A. Guzman-Cottrill, Paul R. Cieslak, Melissa Sutton |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2023-08-01
|
Series: | Emerging Infectious Diseases |
Online Access: | https://wwwnc.cdc.gov/eid/article/29/8/23-0471_article |
Similar Items
-
Correlation between Clinical and Wastewater SARS-CoV-2 Genomic Surveillance, Oregon, USA
by: Devrim Kaya, et al.
Published: (2022-09-01) -
Comparison of Survey Methods in Norovirus Outbreak Investigation, Oregon, USA, 2009
by: John Y. Oh, et al.
Published: (2010-11-01) -
Outbreak of Nontuberculous Mycobacteria Joint Prosthesis Infections, Oregon, USA, 2010–2016
by: Genevieve L. Buser, et al.
Published: (2019-05-01) -
COVID-19 vaccine knowledge, beliefs and attitudes among Oregon healthcare provider types
by: Lisa Corley Stampke, et al.
Published: (2022-07-01) -
Changes in Farmland Ownership in Oregon, USA
by: Megan Horst
Published: (2019-02-01)